Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial".
Journal articles
Schlenk, RF; Montesinos, P; Kim, H-J; Romero-Aguilar, A; Vrhovac, R; Patkowska, E; Žák, P; Wang, P-N; Hanyok, J; Liu, L; Kamel, YM; Cortes, J ...
Published in: Haematologica
April 1, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Haematologica
DOI
EISSN
1592-8721
Publication Date
April 1, 2026
Volume
111
Issue
4
Start / End Page
1509 / 1510
Location
Italy
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Schlenk, R. F., Montesinos, P., Kim, H.-J., Romero-Aguilar, A., Vrhovac, R., Patkowska, E., … Erba, H. P. (2026). Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial". Haematologica, 111(4), 1509–1510. https://doi.org/10.3324/haematol.2025.289379
Schlenk, Richard F., Pau Montesinos, Hee-Je Kim, Antonio Romero-Aguilar, Radovan Vrhovac, Elżbieta Patkowska, Pavel Žák, et al. “Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial".” Haematologica 111, no. 4 (April 1, 2026): 1509–10. https://doi.org/10.3324/haematol.2025.289379.
Schlenk RF, Montesinos P, Kim H-J, Romero-Aguilar A, Vrhovac R, Patkowska E, et al. Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial". Haematologica. 2026 Apr 1;111(4):1509–10.
Schlenk, Richard F., et al. “Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial".” Haematologica, vol. 111, no. 4, Apr. 2026, pp. 1509–10. Pubmed, doi:10.3324/haematol.2025.289379.
Schlenk RF, Montesinos P, Kim H-J, Romero-Aguilar A, Vrhovac R, Patkowska E, Žák P, Wang P-N, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP. Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial". Haematologica. 2026 Apr 1;111(4):1509–1510.
Published In
Haematologica
DOI
EISSN
1592-8721
Publication Date
April 1, 2026
Volume
111
Issue
4
Start / End Page
1509 / 1510
Location
Italy
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology